Status:
UNKNOWN
The Effects of Blood Flow Restriction With Low-intensity Resistance Training Versus Traditional Resistance Exercise on Lower Limb Strength, Walking Capacity, and Balance in Patients With Ischemic Stroke: (BFR-Stroke RESILIENCE Trial)
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Stroke, Ischemic
Cerebrovascular Accident
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Stroke is the leading neurological disease in the world that causes long-term disability. The most common cause of disability after stroke is motor impairment resulting from brain damage which ultimat...
Detailed Description
Blood flow restriction combined with resistance training may be an economic and time-efficient alternative to High-Intensity Training to manage the risk factors of stroke and can also be useful in red...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All the participants will be evaluated to be in stable Cardio-vascular condition i,e ACSM Class B.
- 18 to 90 years of age.
- More than 1 month of stroke onset.
- First ever unilateral ischemic stroke.
- Being able to walk 10 m independently with or without an assistive device.
- Being an independent ambulator (Functional Ambulation Scale\>3).
- Muscle tension of the modified Ashworth scale was lower than grade.
- Exclusion Criteria
- People with a history of mental illness.
- People with obvious cognitive impairments.
- Combination with peripheral neuropathy.
- Having resting blood pressure above 160/100 mmHg even after taking medications.
- Hemorrhagic stroke
- Cardiovascular comorbidity (aortic stenosis, depression of ST-segment, heart failure, arrhythmias, unstable angina, hypertrophic cardiomyopathy).
- Transient ischemic attack.
- By-pass surgery in the recent three months
- Any 0ther musculoskeletal problems that prevented the participants from doing resistance training
- People who have taken antipyretics, analgesics, dopamine, and other drugs that affect autonomic nerve function within 2 weeks.
Exclusion
Key Trial Info
Start Date :
March 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05281679
Start Date
March 20 2022
End Date
December 15 2022
Last Update
March 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Göztepe Prof. Dr. Süleyman Yalçın City Hospital
Istanbul, Turkey (Türkiye), 34160